Sandostatin (Octreotide LAR) May Lead to Clinical Improvement Through Receptor Occupation Optimisation
Conditions:   Neuroendocrine Tumors;   Carcinoid Syndrome Intervention:   Drug: Sandostatin Sponsor:   Cliniques universitaires Saint-Luc- Université Catholique de Louvain Terminated (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2019 Category: Research Source Type: clinical trials

Evaluation of Impact of Sandostatin ® Injection Before Axillary Clearance on Lymphocele Formation
Conditions:   Breast Cancer;   Lymphocele Intervention:   Procedure: Injection of sandostatine Sponsor:   Institut Cancerologie de l'Ouest Terminated (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 3, 2019 Category: Research Source Type: clinical trials